Deflexifol

亚叶酸钙/氟尿嘧啶

Report date: 2025/01/24 16:38:39

Base Information

Drug NameDeflexifol
Drug Alias NameFluorouracil/Leucovorin/Cyclodextrinmetastatic colorectal cancer therapy
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThymidylate synthase inhibitors
TargetsThymidylate synthase
Therapy Area/IndicationsCentral Nervous System Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsYes FluorouracilLeucovorin calcium
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesFivephusion
China Registration ClassN/A

Develop Information

Active CompaniesAustralian And New Zealand Children'S Haematology/Oncology GroupFivephusion
Inactive CompaniesN/A
Active IndicationsCentral Nervous System Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A